Beginning Cash: The amount of cash reported by the company on its previous statement.
EUROFINS SCIENT (ERFSF) had Beginning Cash of $693.77M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$8.25B |
|
$537.19M |
|
$6.49B |
|
$1.77B |
|
$7.32B |
|
$937.48M |
|
$-197.32M |
|
$740.05M |
|
$740.05M |
|
$535.15M |
|
$535.15M |
|
$535.15M |
|
$535.15M |
|
$977.30M |
|
$1.69B |
|
179.80M |
|
186.50M |
|
$0.37 |
|
$0.35 |
|
| Balance Sheet Financials | |
$3.00B |
|
$3.13B |
|
$9.43B |
|
$12.43B |
|
$2.75B |
|
$4.19B |
|
$4.50B |
|
$7.25B |
|
$5.18B |
|
$-871.63M |
|
$5.18B |
|
182.16M |
|
| Cash Flow Statement Financials | |
$1.58B |
|
$-1.22B |
|
$-114.95M |
|
|
Beginning Cash |
$693.77M |
$891.32M |
|
$197.54M |
|
$156.25M |
|
$-124.23M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
0.45 |
|
0.97 |
|
21.39% |
|
11.36% |
|
11.84% |
|
20.47% |
|
8.97% |
|
6.51% |
|
$739.03M |
|
-- |
|
-- |
|
-- |
|
0.66 |
|
41.17 |
|
6.01 |
|
60.69 |
|
10.33% |
|
-61.40% |
|
4.31% |
|
5.71% |
|
$28.43 |
|
$3.96 |
|
$8.49 |
|